Eduard Paschke

3.8k total citations
91 papers, 2.2k citations indexed

About

Eduard Paschke is a scholar working on Physiology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Eduard Paschke has authored 91 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Physiology, 35 papers in Molecular Biology and 21 papers in Clinical Biochemistry. Recurrent topics in Eduard Paschke's work include Lysosomal Storage Disorders Research (58 papers), Glycosylation and Glycoproteins Research (21 papers) and Metabolism and Genetic Disorders (20 papers). Eduard Paschke is often cited by papers focused on Lysosomal Storage Disorders Research (58 papers), Glycosylation and Glycoproteins Research (21 papers) and Metabolism and Genetic Disorders (20 papers). Eduard Paschke collaborates with scholars based in Austria, Germany and Canada. Eduard Paschke's co-authors include Hans Kresse, Gerald Höefler, Barbara Plecko, Kurt Von Figura, Franz Harnoncourt, Gerhard M. Kostner, Wolfgang Erwa, Arnold Stütz, Josef Glössl and Eduard A. Struys and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Eduard Paschke

90 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduard Paschke Austria 27 1.3k 800 493 396 389 91 2.2k
Anaïs Brassier France 19 714 0.5× 608 0.8× 230 0.5× 294 0.7× 168 0.4× 84 1.7k
Enrico Zammarchi Italy 28 626 0.5× 1.7k 2.1× 329 0.7× 269 0.7× 115 0.3× 101 3.2k
Joan Keutzer United States 29 2.3k 1.7× 498 0.6× 673 1.4× 598 1.5× 561 1.4× 50 2.7k
Federica Deodato Italy 23 640 0.5× 801 1.0× 217 0.4× 149 0.4× 114 0.3× 55 1.7k
Helena Hůlková Czechia 20 692 0.5× 692 0.9× 181 0.4× 347 0.9× 94 0.2× 51 1.5k
Masaru Kuriyama Japan 19 669 0.5× 676 0.8× 371 0.8× 263 0.7× 152 0.4× 53 1.7k
Xuefan Gu China 27 487 0.4× 1.4k 1.7× 200 0.4× 170 0.4× 153 0.4× 217 2.5k
Filippo Pinto e Vairo Brazil 20 602 0.5× 569 0.7× 211 0.4× 207 0.5× 88 0.2× 111 1.4k
Stephanie Grünewald United Kingdom 28 516 0.4× 1.4k 1.8× 96 0.2× 217 0.5× 338 0.9× 85 2.1k
Kuniaki Narisawa Japan 31 347 0.3× 1.4k 1.7× 66 0.1× 293 0.7× 247 0.6× 97 2.5k

Countries citing papers authored by Eduard Paschke

Since Specialization
Citations

This map shows the geographic impact of Eduard Paschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Paschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Paschke more than expected).

Fields of papers citing papers by Eduard Paschke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduard Paschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Paschke. The network helps show where Eduard Paschke may publish in the future.

Co-authorship network of co-authors of Eduard Paschke

This figure shows the co-authorship network connecting the top 25 collaborators of Eduard Paschke. A scholar is included among the top collaborators of Eduard Paschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduard Paschke. Eduard Paschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yuskiv, Nataliya, et al.. (2019). Morquio‐B disease: Clinical and genetic characteristics of a distinct GLB1‐related dysostosis multiplex. JIMD Reports. 51(1). 30–44. 13 indexed citations
3.
Tysoe, Christina, Roland C. Fischer, Eduard Paschke, et al.. (2017). N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a G M1 -gangliosidosis related human lysosomal β-galactosidase mutant. Carbohydrate Research. 443-444. 15–22. 5 indexed citations
4.
Lebl, René, Christina Tysoe, Patrick Weber, et al.. (2017). A Morita-Baylis-Hillman based route to C-5a-chain-extended 4-epi-isofagomine type glycosidase inhibitors. Carbohydrate Research. 442. 31–40. 8 indexed citations
5.
Weber, Patrick, Christina Tysoe, Eduard Paschke, et al.. (2017). A new type of pharmacological chaperone for GM1-gangliosidosis related human lysosomal β-galactosidase: N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols. Bioorganic & Medicinal Chemistry Letters. 27(15). 3431–3435. 14 indexed citations
6.
7.
Weber, Patrick, Andrés G. Santana, Roland C. Fischer, et al.. (2016). Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidase. Bioorganic & Medicinal Chemistry Letters. 26(5). 1438–1442. 15 indexed citations
8.
Schwinger, Wolfgang, Petra Sovinz, Martin Benesch, et al.. (2014). Unrelated CD3/CD19-Depleted Peripheral Stem Cell Transplantation for Hurler Syndrome. Pediatric Hematology and Oncology. 31(8). 723–730. 2 indexed citations
9.
Mundigler, Gerald, Martina Gaggl, Georg Heinze, et al.. (2011). The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy. European Journal of Echocardiography. 12(10). 744–749. 29 indexed citations
10.
Paschke, Eduard, Günter Fauler, Axel Schlagenhauf, et al.. (2010). Urinary Total Globotriaosylceramide and Isoforms to Identify Women With Fabry Disease: A Diagnostic Test Study. American Journal of Kidney Diseases. 57(5). 673–681. 15 indexed citations
11.
Hofer, Doris, Michael Beck, Anne Roubergue, et al.. (2010). Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations. Clinical Genetics. 78(3). 236–246. 28 indexed citations
12.
Hofer, Doris, Michael Beck, Catherine Caillaud, et al.. (2009). GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid β-galactosidase. Human Mutation. 30(8). 1214–1221. 41 indexed citations
13.
Steiner, Andreas, Georg Schitter, Arnold Stütz, et al.. (2008). 1-Deoxygalactonojirimycin-lysine hybrids as potent d-galactosidase inhibitors. Bioorganic & Medicinal Chemistry. 16(24). 10216–10220. 21 indexed citations
14.
Plecko, Barbara, Eduard Paschke, Sylvia Stoeckler-Ipsiroglu, et al.. (2006). Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Human Mutation. 28(1). 19–26. 117 indexed citations
15.
Kotanko, Peter, Reinhard Kramar, Eduard Paschke, et al.. (2004). Results of a Nationwide Screening for Anderson-Fabry Disease among Dialysis Patients. Journal of the American Society of Nephrology. 15(5). 1323–1329. 150 indexed citations
16.
Lorenz, Matthias, Peter Kotanko, Reinhard Kramar, et al.. (2003). Anderson-Fabry disease in Austria. Wiener klinische Wochenschrift. 115(7-8). 235–240. 7 indexed citations
17.
18.
Stöckler, Sylvia, O. Ipsiroglu, & Eduard Paschke. (1989). Angeborene Stoffwechselerkrankungen als Ursache akuter Krankheitsbilder in der Neugeborenenperiode. Klinische Pädiatrie. 201(5). 369–372.
19.
Schmidberger, Heinz, Kurt Von Figura, K. Harzer, et al.. (1980). Morquio syndrome (mucopolysaccharidosis IV B) associated with beta-galactosidase deficiency. Report of two cases.. PubMed. 32(2). 258–72. 51 indexed citations
20.
Paschke, Eduard. (1955). Zur Kenntnis der Glukosebestimmung nach Hagedorn und Jensen. Microchimica Acta. 43(5-6). 983–986. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anaïs Brassier Breakdown of academic impact, for papers by Enrico Zammarchi Breakdown of academic impact, for papers by Joan Keutzer Breakdown of academic impact, for papers by Federica Deodato Breakdown of academic impact, for papers by Helena Hůlková Breakdown of academic impact, for papers by Masaru Kuriyama Breakdown of academic impact, for papers by Xuefan Gu Breakdown of academic impact, for papers by Filippo Pinto e Vairo Breakdown of academic impact, for papers by Stephanie Grünewald Breakdown of academic impact, for papers by Kuniaki Narisawa
Rankless by CCL
2026